Plant Comparison
Flaxseed vs Rosemary
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Flaxseed and Rosemary: they share 7 indicated uses (arthritis / joint pain, bloating, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Flaxseed | Rosemary | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 3/10 | 3/10 | Comparable evidence |
| Bloating | 3/10 | 3/10 | Comparable evidence |
| Cancer (anticancer research) | 7/10 | 7/10 | Comparable evidence |
| Cardiovascular / heart health | 6/10 | 3/10 | Stronger for Flaxseed |
| Indigestion | 3/10 | 3/10 | Comparable evidence |
| Inflammation (general) | 3/10 | 8/10 | Stronger for Rosemary |
| Skin irritation | 3/10 | 3/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Flax is the richest dietary source of SDG-type lignans, converted by gut bacteria to the mammalian lignans enterodiol and enterolactone; studied for antioxidant and hormone-modulating activity.
The dominant fatty acid of the seed oil (~50-55% of total oil), a plant-based omega-3 studied for cardiovascular and anti-inflammatory effects.
Concentrated in the seed coat; gives flaxseed its demulcent, laxative, bulk-forming action.
Present at low levels; cooking/roasting reduces them to negligible amounts in normal food use - a theoretical concern only at high raw intakes.
The volatile oil, dominated by 1,8-cineole and camphor, gives the characteristic aroma and much of the antimicrobial activity.
Potent antioxidant diterpenes considered largely responsible for rosemary's strong preservative and antioxidant activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from digestive action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from neuroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Flaxseeds are safe for most people at recommended food amounts (1–2 tablespoons ground/day). They must be ground or milled to be bioavailable — whole seeds largely pass through the gut undigested. High fibre content may cause bloating, flatulence, and loose stools, especially if fibre intake is increased rapidly without adequate hydration. Flaxseeds contain cyanogenic glycosides (linamarin, linustatin); cooking or roasting reduces these to negligible levels in normal food amounts. Raw seeds in very large quantities are a theoretical concern, but typical use is safe (EFSA, 2017).
Medication interactions: Flaxseed may reduce absorption of oral medications if taken simultaneously — space flaxseed supplementation 1–2 hours from medications. Omega-3 ALA and lignans may mildly enhance anticoagulant/antiplatelet effects; use caution with blood thinners. Some sources suggest caution with hormone-sensitive conditions due to phytoestrogen (lignan) content, though dietary amounts are unlikely to pose risk (Adolphe et al., 2010).
Pregnancy: Food amounts are generally considered safe; high-dose supplements should be discussed with a clinician due to limited safety data.
Duke (2002) rates flaxseed as +++ with clinical evidence (score 2) for antiatherogenic, hypocholesterolemic, laxative, lipolytic (fat-dissolving), and demulcent activities. Flaxseed's omega-3 fatty acids (ALA) and lignans are associated with reduced cardiovascular risk. Commission E approves flaxseed as a laxative and for mucilaginous protection of inflamed gastrointestinal mucosa. Dose: 1–2 tablespoons ground seed with ample water, twice daily. Whole seeds should be chewed or ground for full medicinal effect. Cyanogenic glycosides are present but at safe levels in normal dietary amounts (Duke, 2002).
Culinary use is entirely safe. Essential oil should not be ingested in large amounts; avoid during pregnancy in medicinal doses. May trigger epileptic seizures in predisposed individuals at high doses. May interact with anticoagulants and antiplatelet drugs.
Duke (2002) does not appear to include a dedicated entry for rosemary (Salvia rosmarinus / Rosmarinus officinalis) as a primary herb entry in the section searched; however, rosemary is referenced throughout the text in relation to antioxidant and antimicrobial properties of its key compounds (carnosol, rosmarinic acid). Commission E (KOM) approves rosemary for dyspeptic complaints and externally for rheumatic conditions and circulatory problems.
External Ids
Botanical Description
Erect annual herb, slender and often branched near the top, growing 30-80 (up to 100) cm tall from a fine taproot. Leaves are alternate, sessile, narrowly lanceolate to linear, blue-green and entire-margined. Flowers are pale blue (occasionally white or pink), five-petalled and borne on slender stalks in loose terminal cymes. The fruit is a small globular capsule ('boll') that splits into ten compartments, each containing one flattened, glossy, red-brown seed.[5]
Evergreen, woody shrub (Lamiaceae), 1-2 m tall, with dense, needle-like, dark green, aromatic leaves, white-felted beneath. Small, pale blue to violet, two-lipped flowers are borne in the leaf axils.[1]
Habitat
Native to the Mediterranean region and the Fertile Crescent, cultivated since prehistory for fibre and oil and now grown worldwide in temperate regions with well-drained, fertile soils and a cool, moist growing season; occasionally found as a naturalised escape on waste and cultivated ground.[5]
Native to the Mediterranean coast, growing on dry, rocky, sunny slopes and coastal scrub; widely cultivated as a culinary and medicinal herb worldwide, tolerating poor, well-drained soils and drought.[1]
Harvesting
Grown as an annual crop, seed is harvested once the capsules ('bolls') have dried and turned brown, typically in late summer, by cutting or combining the whole plant and threshing out the seed. Whole seed stores well; it should only be ground shortly before use, since the oil in ground seed oxidises and turns rancid quickly.[2]
Leafy sprigs are cut throughout the year (the plant is evergreen), though essential-oil content is often considered highest just before or during flowering; leaves are stripped from the stem and dried, or used fresh.[1]
Traditional Uses
Flaxseed has a long history of traditional use as a bulk-forming laxative and demulcent for constipation and irritated gut mucosa, and as a poultice for boils and inflamed skin. Modern interest centres on its lignan (secoisolariciresinol diglucoside) and alpha-linolenic acid content, studied for cardiovascular, metabolic and hormone-related outcomes.[2, 4, 5]
Rosemary has an ancient Mediterranean reputation as a memory and circulation tonic ('rosemary for remembrance'), a digestive carminative, and an antiseptic for minor wounds. Commission E approves it for dyspeptic complaints internally and for rheumatic conditions and circulatory problems externally; modern research on rosmarinic acid and carnosic acid supports antioxidant, anti-inflammatory, antimicrobial and cognitive-supportive activity.[1]
Preparations
Whole seed freshly ground (milled) and taken with plenty of liquid, or stirred into food; grinding is needed to make the oil and lignans bioavailable, as whole seeds largely pass through the gut undigested.
Cold-pressed oil taken as a concentrated source of alpha-linolenic acid (omega-3); lacks the fibre and lignan content of the whole ground seed.
Dosage
Traditional guidance and Duke (2002) suggest 1-2 tablespoons of ground seed with ample water, once or twice daily. Educational reference only, not a prescription.
A randomised placebo-controlled trial titrated flax oil capsules (550 mg alpha-linolenic acid per 1 g of oil) to 12 capsules per day, i.e. up to roughly 12 g of oil daily, over 16 weeks - broadly matching the 1-2 tablespoons (about 10-15 mL) daily often cited for omega-3 intake. That trial was in children and adolescents with bipolar disorder and its primary outcomes were null; it is cited here only as a source for an administered human dose of the oil, not as evidence of benefit. Note the EU herbal monograph on Lini semen covers the SEED, not the oil. Educational reference only, not a prescription.
Commission E approves rosemary for dyspeptic complaints (internal use) and, externally, for rheumatic conditions and circulatory problems; typical internal use is roughly 2-4 g dried leaf as tea, up to three times daily. Educational reference only, not a prescription; avoid concentrated essential oil internally and in pregnancy/epilepsy.
References
Lookalikes Review
References & Sources
- Picur, B., Cebrat, M., Zabrocki, J. and Siemion, I.Z (2006) 'Cyclopeptides of Linum usitatissimum', Journal of Peptide Science, 12(9), pp. 569-574. doi:10.1002/psc.779 Preclinical
https://doi.org/10.1002/psc.779 - Basch, E., Bent, S., Collins, J., Dacey, C., Hammerness, P., Harrison, M., Smith, M., Szapary, P., Ulbricht, C., Vora, M. and Weissner, W (2007) 'Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration', Journal of the Society for Integrative Oncology, 5(3), pp. 92-105. doi:10.2310/7200.2007.005 Meta-analysis / review
https://doi.org/10.2310/7200.2007.005 - Chhillar, H., Chopra, P. and Ashfaq, M.A (2020) 'Lignans from linseed (Linum usitatissimum L.) and its allied species: retrospect, introspect and prospect', Critical Reviews in Food Science and Nutrition, 61(16), pp. 2719-2741. doi:10.1080/10408398.2020.1784840 Meta-analysis / review
https://doi.org/10.1080/10408398.2020.1784840 - Ansari, R., Zarshenas, M.M. and Dadbakhsh, A.H (2019) 'A review on pharmacological and clinical aspects of Linum usitatissimum L', Current Drug Discovery Technologies, 16(2), pp. 148-158. doi:10.2174/1570163815666180521101136 Meta-analysis / review
https://doi.org/10.2174/1570163815666180521101136 - Akter, Y., Junaid, M., Afrose, S.S., Nahrin, A., Alam, M.S., Sharmin, T., Akter, R. and Hosen, S.M.Z (2021) 'A comprehensive review on Linum usitatissimum medicinal plant: its phytochemistry, pharmacology, and ethnomedicinal uses', Mini Reviews in Medicinal Chemistry, 21(18), pp. 2801-2834. doi:10.2174/1389557521666210203153436 Meta-analysis / review
https://doi.org/10.2174/1389557521666210203153436 - Musazadeh, V., Abolghasemian, M., Kavyani, Z., Moridpour, A.H., Nazari, A. and Faghfouri, A.H (2024) 'The effects of flaxseed (Linum usitatissimum) supplementation on anthropometric indices: an updated systematic review and meta-analysis of randomized clinical trials', Complementary Therapies in Medicine, 84, pp. 103066. doi:10.1016/j.ctim.2024.103066 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2024.103066 - Mueed, A., Shibli, S., Jahangir, M., Jabbar, S. and Deng, Z (2022) 'A comprehensive review of flaxseed (Linum usitatissimum L.): health-affecting compounds, mechanism of toxicity, detoxification, anticancer and potential risk', Critical Reviews in Food Science and Nutrition, 63(32), pp. 11081-11104. doi:10.1080/10408398.2022.2092718 Meta-analysis / review
https://doi.org/10.1080/10408398.2022.2092718 - Kaithwas, G., Mukherjee, A., Chaurasia, A.K. and Majumdar, D.K (2011) 'Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixed oil', Indian Journal of Experimental Biology, 49(12), pp. 932-938. Preclinical
https://scholar.google.com/scholar?q=Anti-inflammatory%2C%20analgesic%20and%20antipyretic%20activities%20of%20Linum%20usitatissimum%20L.%20%28flaxseed/linseed%29%20fixed%20oil - Rafieian-Kopaei, M., Shakiba, A., Sedighi, M. and Bahmani, M (2017) 'The analgesic and anti-inflammatory activity of Linum usitatissimum in Balb/c mice', Journal of Evidence-Based Complementary & Alternative Medicine, 22(4), pp. 892-896. doi:10.1177/2156587217717416 Preclinical
https://doi.org/10.1177/2156587217717416 - Sirotkin, A.V (2023) 'Influence of flaxseed (Linum usitatissimum) on female reproduction', Planta Medica, 89(6), pp. 608-615. doi:10.1055/a-2013-2966 Meta-analysis / review
https://doi.org/10.1055/a-2013-2966 - Thompson, L.U., Chen, J.M., Li, T., Strasser-Weippl, K. and Goss, P.E (2006) 'Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer', 11(10), pp. 3828--3835. doi:10.1158/1078-0432.CCR-04-2326 Randomized trial
https://doi.org/10.1158/1078-0432.CCR-04-2326 - Adolphe, J.L., Whiting, S.J., Juurlink, B.H.J., Thorpe, L.U. and Alcorn, J (2010) 'Health effects with consumption of the flax lignan secoisolariciresinol diglucoside', 103(7), pp. 929--938. doi:10.1017/S0007114509992753 Clinical study
https://doi.org/10.1017/S0007114509992753 - Caligiuri, S.P.B., Edel, A.L., Aliani, M. and Pierce, G.N (2014) 'Flaxseed for hypertension: implications for improved cardiovascular risk', 16(12), pp. 499. doi:10.1007/s11906-014-0499-8 Randomized trial
https://doi.org/10.1007/s11906-014-0499-8 - European Food Safety Authority (2017) 'Safety of cyanogenic glycosides from flaxseed consumed as part of a usual diet', 15(11). doi:10.2903/j.efsa.2017.5026 Preclinical
https://doi.org/10.2903/j.efsa.2017.5026 - Harris, W.S (2012) 'Stearidonic acid as a surrogate for eicosapentaenoic acid in cardiovascular risk reduction: update and recommendation', 70(10), pp. 565--574. Traditional / reference
https://scholar.google.com/scholar?q=Stearidonic%20acid%20as%20a%20surrogate%20for%20eicosapentaenoic%20acid%20in%20cardiovascular%20risk%20reduction%3A%20update%20and%20recommendation - Latvijas valsts mežzinātnes institūts (n.d.) 'Linsēkla Latvijā'. Available at: https://www.silava.lv Traditional / reference
https://www.silava.lv - Pan, A., Sun, J., Chen, Y. et al (2009) 'Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial', 4(11). doi:10.1371/journal.pone.0007654 Randomized trial
https://doi.org/10.1371/journal.pone.0007654 - Royal Botanic Gardens, Kew (n.d.) 'Linum usitatissimum L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 - Gracious, B.L., Chirieac, M.C., Costescu, S., Finucane, T.L., Youngstrom, E.A. and Hibbeln, J.R (2010) 'Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder', Bipolar Disorders, 12(2), pp. 142-154. doi:10.1111/j.1399-5618.2010.00799.x Randomized trial
https://doi.org/10.1111/j.1399-5618.2010.00799.x - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- de Oliveira, J.R., Camargo, S.E.A. and de Oliveira, L.D (2019) 'Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent', Journal of Biomedical Science, 26(1), pp. 5. doi:10.1186/s12929-019-0499-8 Meta-analysis / review
https://doi.org/10.1186/s12929-019-0499-8 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2025) 'Toxicity and safety of rosemary (Rosmarinus officinalis): a comprehensive review', Naunyn-Schmiedeberg's Archives of Pharmacology, 398(1), pp. 9-23. doi:10.1007/s00210-024-03336-9 Meta-analysis / review
https://doi.org/10.1007/s00210-024-03336-9 - Zhang, L. and Lu, J (2024) 'Rosemary (Rosmarinus officinalis L.) polyphenols and inflammatory bowel diseases: Major phytochemicals, functional properties, and health effects', Fitoterapia, 177, pp. 106074. doi:10.1016/j.fitote.2024.106074 Meta-analysis / review
https://doi.org/10.1016/j.fitote.2024.106074 - Ahmed, H.M. and Babakir-Mina, M (2020) 'Investigation of rosemary herbal extracts (Rosmarinus officinalis) and their potential effects on immunity', Phytotherapy Research, 34(8), pp. 1829-1837. doi:10.1002/ptr.6648 Preclinical
https://doi.org/10.1002/ptr.6648 - Li, T., Wang, W., Guo, Q., Li, J. and others (2023) 'Rosemary (Rosmarinus officinalis L.) hydrosol based on serotonergic synapse for insomnia', Journal of Ethnopharmacology, 318(Pt B), pp. 116984. doi:10.1016/j.jep.2023.116984 Preclinical
https://doi.org/10.1016/j.jep.2023.116984 - Hassani, F.V., Shirani, K. and Hosseinzadeh, H (2016) 'Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review', Naunyn-Schmiedeberg's Archives of Pharmacology, 389(9), pp. 931-949. doi:10.1007/s00210-016-1256-0 Meta-analysis / review
https://doi.org/10.1007/s00210-016-1256-0 - Gonzalez-Vallinas, M., Reglero, G. and Ramirez de Molina, A (2015) 'Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy', Nutrition and Cancer, 67(8), pp. 1221-1229. doi:10.1080/01635581.2015.1082110 Meta-analysis / review
https://doi.org/10.1080/01635581.2015.1082110 - Hussain, S.M., Syeda, A.F., Alshammari, M., Alnasser, S. and others (2022) 'Cognition enhancing effect of rosemary (Rosmarinus officinalis L.) in lab animal studies: a systematic review and meta-analysis', Brazilian Journal of Medical and Biological Research, 55, pp. e11593. doi:10.1590/1414-431X2021e11593 Meta-analysis / review
https://doi.org/10.1590/1414-431X2021e11593 - Nematolahi, P., Mehrabani, M., Karami-Mohajeri, S. and Dabaghzadeh, F (2018) 'Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial', Complementary Therapies in Clinical Practice, 30, pp. 24-28. doi:10.1016/j.ctcp.2017.11.004 Randomized trial
https://doi.org/10.1016/j.ctcp.2017.11.004 - Ulbricht, C., Abrams, T.R., Brigham, A., Ceurvels, J. and others (2010) 'An evidence-based systematic review of rosemary (Rosmarinus officinalis) by the Natural Standard Research Collaboration', Journal of Dietary Supplements, 7(4), pp. 351-413. doi:10.3109/19390211.2010.525049 Meta-analysis / review
https://doi.org/10.3109/19390211.2010.525049 - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Moss, M., Cook, J., Wesnes, K. and Duckett, P (2003) 'Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults', 113(1), pp. 15--38. doi:10.1080/00207450390161903 Clinical study
https://doi.org/10.1080/00207450390161903 - Petersen, M. and Simmonds, M.S.J (2003) 'Rosmarinic acid', 62(2), pp. 121--125. Traditional / reference
https://scholar.google.com/scholar?q=Rosmarinic%20acid - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.